Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14,390 JPY | -0.79% | -0.28% | -11.64% |
Apr. 12 | Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months | MT |
Apr. 12 | COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.64% | 3.7B | |
-0.09% | 3.4B | |
-23.44% | 3.07B | |
+7.56% | 2.72B | |
+6.72% | 2.58B | |
-9.26% | 1.74B | |
+9.30% | 1.38B | |
-20.60% | 958M | |
-38.62% | 702M | |
-0.53% | 449M |
- Stock Market
- Equities
- 3349 Stock
- News COSMOS Pharmaceutical Corporation
- UBS Adjusts Cosmos Pharmaceutical's Price Target to 16,500 Yen From 17,500 Yen, Keeps at Neutral